Our top pick for
Plantronics, Inc is a communication equipment business based in the US. Plantronics shares (PLT) are listed on the NYSE and all prices are listed in US Dollars. Plantronics employs 6,584 staff and has a trailing 12-month revenue of around USD$1.7 billion.
|52-week range||USD$4.6 - USD$46.15|
|50-day moving average||USD$37.2718|
|200-day moving average||USD$23.9616|
|Wall St. target price||USD$45|
|Dividend yield||USD$0 (0%)|
|Earnings per share (TTM)||USD$-4.968|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Plantronics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Plantronics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Plantronics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Plantronics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Plantronics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$161.5 million.
The EBITDA is a measure of a Plantronics's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.7 billion|
|Gross profit TTM||USD$738.1 million|
|Return on assets TTM||-0.26%|
|Return on equity TTM||-314.16%|
|Market capitalisation||USD$1.7 billion|
TTM: trailing 12 months
There are currently 2.6 million Plantronics shares held short by investors – that's known as Plantronics's "short interest". This figure is 20.4% down from 3.3 million last month.
There are a few different ways that this level of interest in shorting Plantronics shares can be evaluated.
Plantronics's "short interest ratio" (SIR) is the quantity of Plantronics shares currently shorted divided by the average quantity of Plantronics shares traded daily (recently around 636575.73529412). Plantronics's SIR currently stands at 4.08. In other words for every 100,000 Plantronics shares traded daily on the market, roughly 4080 shares are currently held short.
However Plantronics's short interest can also be evaluated against the total number of Plantronics shares, or, against the total number of tradable Plantronics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Plantronics's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Plantronics shares in existence, roughly 60 shares are currently held short) or 0.0905% of the tradable shares (for every 100,000 tradable Plantronics shares, roughly 91 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Plantronics.
Find out more about how you can short Plantronics stock.
We're not expecting Plantronics to pay a dividend over the next 12 months.
Plantronics's shares were split on a 3:1 basis on 9 August 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Plantronics shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Plantronics shares which in turn could have impacted Plantronics's share price.
Over the last 12 months, Plantronics's shares have ranged in value from as little as $4.6 up to $46.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Plantronics's is 1.8613. This would suggest that Plantronics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Plantronics, Inc. designs, manufactures, markets, and sells integrated communications and collaborations solutions for corporate customers, small businesses, and individuals worldwide. Its principal product categories include headsets, which comprises wired and wireless communication headsets; voice, video, and content sharing solutions, which includes open session initiation protocol and native ecosystem desktop phones, conference room phones, and video conferencing solutions; peripherals, including cameras, speakers, and microphones designed to work with a range of unified communication and collaboration, unified communication as a service, and video as a service environments, including RealPresence collaboration solutions of infrastructure to endpoints that allows people to connect and collaborate; and support services. The company sells its products through a sales team, as well as through value-added resellers, integrators, direct marketing resellers, service providers, direct and indirect resellers, retailer, enterprise distributors, wireless carriers, and mass merchants under the Poly, Plantronics, and Polycom brands, as well as RIG brand. Plantronics, Inc. was founded in 1961 and is headquartered in Santa Cruz, California.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.